CTRI/2025/09/094432尚未招募4 期
Comparative efficacy of Nepafenac 0.3 percent once daily versus Nepafenac 0.1 percent thrice daily eyedrops in preventing macular edema following pan retinal photocoagulation in diabetic retinopathy.
Dr Supriya Pandharinath Dhondge1 个研究点 分布在 1 个国家目标入组 76 人开始时间: 2025年9月19日最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 76
- 试验地点
- 1
- 主要终点
- visual Acquity (by LogMAR chart)
研究概览
简要总结
To compare the efficacy of Nepafenac 0.3 percent once daily versus Nepafenac 0.1 percent three times a day in preventing an increase in central macular thickness following Pan Retinal Photocoagulation in Diabetic Retinopathy
To Assess changes in best corrected visual acuity by LogMAR and evaluate the changes in Central Macular Thickness by OCT after PRP1, after PRP2, after PRP3 and 1 month, 2 months and 3 months after PRP3.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 盲法
- None
入排标准
- 年龄范围
- 40.00 Year(s) 至 80.00 Year(s)（—）
- 性别
- All
入选标准
- •1.All cases undergoing Pan retinal photocoagulation with proliferative Diabetic Retinopathy 2.Central Macular Thickness less than 300 microns.
排除标准
- •1.Dry eye 2.Prior history of intravitreal injections or focal laser less than 6 months ago 3.Presence of incomplete Pan retinal photocoagulation 4.Any vitreo-retinal interface pathology like epiretinal membrane or vitreo-macular traction 5.Patients who lost follow up.
结局指标
主要结局
visual Acquity (by LogMAR chart)
时间窗: after PRP1, after PRP2, after PRP3 and 1 month, 2 months and 3 months after PRP3.
次要结局
- Central Macular Thickness (Documented by OCT)(after PRP1, after PRP2, after PRP3 and 1 month, 2 months and 3 months after PRP3.)
研究者
Dr Supriya Pandharinath Dhondge
Sankara Eye Hospital ,Guntur ,Andhra Pradesh
研究点 (1)
Loading locations...
相似试验
进行中（未招募）
4 期
A Comparative Analysis of the Effectiveness of Nepafenac Combined With a Lubricant Versus a Lubricant Alone in the Treatment of Epiphora Associated With Lacrimal Punctum StenosisNCT07372014Instituto de Oftalmología Fundación Conde de Valenciana68
尚未招募
2 期
A Clinical Study Comparing 12.5% and 25% Dextrose Injections for Treating TMJ Disorders.CTRI/2026/02/103368Dr Jyothsna M24
尚未招募
3 期
AMAZE 8: A Research Study Investigating How Well the Medicine NNC0487-0111 Compared to Semaglutide Helps People With Excess Body Weight and Type 2 Diabetes Lose WeightDiabetes Mellitus, Type 2ObesityNCT07400107Novo Nordisk A/S1,000
招募中
3 期
AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose WeightNCT07339423Novo Nordisk A/S1,150
招募中
4 期
LOW DOse vs standard dose and administration TIme in near-infrared fluorescence cholangiography during laparoscopic cholecystectomy: a randomised clinical trial.2025-522535-33-00Fundacion Instituto De Estudios De Ciencias De La Salud De Castilla Y Leon122